Moldoveanu Z, Novak M, Huang W Q, Gilley R M, Staas J K, Schafer D, Compans R W, Mestecky J
Secretech, Inc., Controlled Release Division, Birmingham, AL 35205.
J Infect Dis. 1993 Jan;167(1):84-90. doi: 10.1093/infdis/167.1.84.
Polymeric microspheres were evaluated as an oral antigen delivery system for immunization with influenza virus. The immune responses obtained were compared after either oral or systemic immunization of BALB/c mice using purified, formalin-inactivated influenza virus type A/H3N2, either encapsulated in biodegradable and biocompatible microspheres or free in solution. The immunogenicity of formalin-treated influenza vaccine was preserved during the microencapsulation process, and the microencapsulated antigen induced protective immune responses after systemic immunization that were equal to or higher than those induced by conventional vaccine. When administered orally to primed animals, microencapsulated antigen induced levels of anti-influenza antibodies in saliva that were higher than and in serum that were comparable to those obtained by systemic immunization. Furthermore, oral booster immunization provided virtually complete protection of animals challenged with live virus.
聚合物微球被评估为一种用于流感病毒免疫的口服抗原递送系统。使用纯化的、福尔马林灭活的甲型H3N2流感病毒,分别以包封于可生物降解且生物相容的微球中或游离于溶液中的形式,对BALB/c小鼠进行口服或全身免疫后,比较所获得的免疫反应。在微囊化过程中,福尔马林处理的流感疫苗的免疫原性得以保留,并且微囊化抗原在全身免疫后诱导的保护性免疫反应与传统疫苗诱导的反应相当或更高。当对致敏动物进行口服给药时,微囊化抗原诱导的唾液中抗流感抗体水平高于全身免疫,血清中的抗流感抗体水平与全身免疫相当。此外,口服加强免疫几乎为感染活病毒的动物提供了完全保护。